The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
TGF-β signaling alterations and susceptibility to colorectal cancer
Open accessAbstract
In 2006, more than 55,000 patients died of colorectal cancer in the US, accounting for approximately 10% of all cancer deaths. Despite significant progress in screening combined with the development of novel effective therapies, colorectal cancer ranks second to lung cancer as a cause of cancer death. Twin studies indicate that 35% of all colorectal cancers are inherited, but high-penetrance tumor susceptibility genes only account for approximately 3-6% of all cases. The remainder of the unexplained familial risk is presumably due to other high-penetrance genes, but polygenic mechanisms and low-penetrance tumor susceptibility genes are likely to account for a greater proportion of familial colorectal cancers. In this regard, there is growing evidence that a common hypomorphic variant of the type I TGF-beta receptor, TGFBR1*6A, may account for approximately 3% of all colorectal cancer cases, a fraction higher than that attributable to mismatch repair genes MLH1, MSH2, MSH6 and PMS2. Furthermore, TGFBR1*6A is emerging as a potent modifier of colorectal cancer risk among individuals with a strong family of colorectal cancer. The TGF-beta signaling pathway plays a central but paradoxical role in the predisposition and progression of colorectal cancer. TGF-beta is a potent inhibitor of normal colonic epithelial cells acting as a tumor suppressor. However, TGF-beta promotes the survival, invasion and metastasis of colorectal cancer cells, thereby acting as an oncogene. Understanding how selective alterations of the TGF-beta signaling pathway contribute to colorectal cancer development and progression will likely permit the identification of an additional fraction of inherited colorectal cancer cases and provide novel opportunities for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
Al-Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N., Livingston, A. L., Williams, G. T., Hodges, A. K., Davies, D. R., David, S. S., Sampson, J. R., et al. (2002) · Nature Genetics · doi:10.1038/ng828 · Cited by 1,394
Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 950
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Järvinen, H. J., Sistonen, P., Tomlinson, I. P. M., Houlston, R. S., Bevan, S., Mitros, F. A., et al. (1998) · Science · doi:10.1126/science.280.5366.1086 · Cited by 907
Yang, X. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1280 · Cited by 889
Role of Transforming Growth Factor Beta in Human Cancer
Elliott, R. L., & Blobe, G. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.047 · Cited by 709
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
Laken, S. J., Petersen, G. M., Gruber, S. B., Oddoux, C., Ostrer, H., Giardiello, F. M., Hamilton, S. R., Hampel, H., Markowitz, A., Klimstra, D., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-79 · Cited by 683
Smad3 Mutant Mice Develop Metastatic Colorectal Cancer
Zhu, Y., Richardson, J. A., Parada, L. F., & Graff, J. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81730-4 · Cited by 671
Genetic predisposition to colorectal cancer
de la Chapelle, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1453 · Cited by 661
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis
Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., Velculescu, V. E., Traverso, G., & Vogelstein, B. (2001) · Nature Genetics · doi:10.1038/88919 · Cited by 629
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Pathology of mouse models of intestinal cancer: Consensus report and recommendations
Boivin, G. P., Washington, K., Yang, K., Ward, J. M., Pretlow, T. P., Russell, R., Besselsen, D. G., Godfrey, V. L., Doetschman, T., Dove, W. F., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50094 · Cited by 496
Colorectal Cancer Screening: Scientific Review
Walsh, J. M. E., & Terdiman, J. P. (2003) · JAMA · doi:10.1001/jama.289.10.1288 · Cited by 419
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J., Neumann, A., Brattain, M. G., Chang, J., Kim, S., et al. (1999) · PubMed · Cited by 391
Levy, L., & Hill, C. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8108-8125.2005 · Cited by 342
Smad4 signalling in T cells is required for suppression of gastrointestinal cancer
Kim, B.-G., Li, C., Qiao, W., Mamura, M., Kasperczak, B., Anver, M., Wolfraim, L., Hong, S., Mushinski, E., Potter, M., et al. (2006) · Nature · doi:10.1038/nature04846 · Cited by 322
GENETIC AND EPIGENETIC ALTERATIONS IN COLON CANCER
Grady, W. M., & Markowitz, S. D. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103043 · Cited by 316
Colorectal cancer: genetics of development and metastasis
Takayama, T., Miyanishi, K., Hayashi, T., Sato, Y., & Niitsu, Y. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1801-6 · Cited by 265
Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis
Sweet, K. (2005) · JAMA · doi:10.1001/jama.294.19.2465 · Cited by 234
Helicobacter Infection Is Required for Inflammation and Colon Cancer in Smad3-Deficient Mice
Maggio-Price, L., Treuting, P., Zeng, W., Tsang, M., Bielefeldt-Ohmann, H., & Iritani, B. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2448 · Cited by 209
Friedman, E. D., Gold, L. I., Klimstra, D., Zeng, Z., Winawer, S. J., & Cohen, A. M. (1995) · PubMed · Cited by 182
Muñoz, N. M., Upton, M., Rojas, A., Washington, M. K., Lin, L., Chytil, A., Sozmen, E. G., Madison, B. B., Pozzi, A., Moon, R. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0890 · Cited by 169
TbetaR-I(6A) is a candidate tumor susceptibility allele.
Pasche, B., Kolachana, P., Nafa, K., Satagopan, J. M., Chen, Y., Lo, R. S., Brener, D., Yang, D. D., Kirstein, L., Oddoux, C., et al. (1999) · PubMed · Cited by 163
Self-citationTGFβ signaling in health and disease
Akhurst, R. J. (2004) · Nature Genetics · doi:10.1038/ng0804-790 · Cited by 154
Biswas, S., Chytil, A. M., Washington, K., Romero–Gallo, J., Gorska, A. E., Wirth, P. S., Gautam, S., Moses, H. L., & Grady, W. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3255 · Cited by 153
The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer
Mishra, L., Shetty, K., Tang, Y., Stuart, A., & Byers, S. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208924 · Cited by 151
Hoosein, N. M., McKnight, M. K., Levine, A. E., Mulder, K. M., Childress‐Fields, K. E., Brattain, D. E., & Brattain, M. G. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90101-8 · Cited by 143
Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J. K. V., Sun, L., & Brattain, M. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17366 · Cited by 120
TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies
Kaklamani, V., Hou, N., Bian, Y., Reich, J., Offit, K., Michel, L. S., Rubinstein, W. S., RADEMAKER, A. W., & Pasche, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.524 · Cited by 107
Self-citationRobson, H., Anderson, E., James, R., & Schofield, P. F. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.432 · Cited by 103
Structural alterations of transforming growth factor-? receptor genes in human cervical carcinoma
Chen, T., de Vries, E. G. E., Hollema, H., Yegen, H. A., Vellucci, V. F., Strickler, H. D., Hildesheim, A., & Reiss, M. (1999) · International Journal of Cancer · Cited by 100
Yamagata, H., Matsuzaki, K., Mori, S., Yoshida, K., Tahashi, Y., Furukawa, F., Sekimoto, G., Watanabe, T., Uemura, Y., Sakaida, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.157.65.1 · Cited by 97
Pasche, B., Luo, Y., Rao, P. H., Nimer, S. D., Dmitrovsky, E., Caron, P., Luzzatto, L., Offit, K., Cordón-Cardó, C., Renault, B., et al. (1998) · PubMed · Cited by 96
Self-citationSomatic Acquisition and Signaling of TGFBR1 *6A in Cancer
Pasche, B., Knobloch, T. J., Bian, Y., Liu, J., Phukan, S., Rosman, D., Kaklamani, V., Baddi, L., Siddiqui, F., Frankel, W., et al. (2005) · JAMA · doi:10.1001/jama.294.13.1634 · Cited by 92
Self-citationSmad3 Deficiency Promotes Tumorigenesis in the Distal Colon of ApcMin/+ Mice
Sodir, N. M., Chen, X., Park, R. J.-H., Nickel, A. E., Conti, P. S., Moats, R. A., Bading, J. R., Shibata, D. K., & Laird, P. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1437 · Cited by 89
TGFBR1*6A and Cancer: A Meta-Analysis of 12 Case-Control Studies
Pasche, B., Kaklamani, V., Hou, N., Young, T., Rademaker, A., Peterlongo, P., Ellis, N., Offit, K., Caldes, T., Reiss, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.271 · Cited by 88 · cited 1×
“A second updated meta-analysis of 12 case–control studies that included 7850 individuals confirmed these original findings (42).”
BackgroundSelf-citationAn update on the genetics of colorectal cancer
Kemp, Z., Thirlwell, C., Sieber, O., Silver, A., & Tomlinson, I. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh247 · Cited by 87
Hamamoto, T., Beppu, H., Okada, H., Kawabata, M., Kitamura, T., Miyazono, K., & Kato, M. (2002) · PubMed · Cited by 79
Smad4 haploinsufficiency in mouse models for intestinal cancer
Alberici, P., Jagmohan–Changur, S., de Pater, E., van der Valk, M., Smits, R., Hohenstein, P., & Fodde, R. (2005) · Oncogene · doi:10.1038/sj.onc.1209226 · Cited by 77
Baxter, S. W., Choong, D. Y. H., Eccles, D., & Campbell, I. (2002) · PubMed · Cited by 59
Sheng, H., Shao, J., O'Mahony, C. A., Lamps, L. W., Albo, D., Isakson, P. C., Berger, D. H., DuBois, R. N., & Beauchamp, R. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202397 · Cited by 56
Ilyas, M., Efstathiou, J. A., Straub, J., Kim, H. C., & Bodmer, W. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3087 · Cited by 55
Evidence of Linkage to Chromosome 9q22.33 in Colorectal Cancer Kindreds from the United Kingdom
Kemp, Z., Carvajal‐Carmona, L. G., Barclay, E., Gorman, M., Martin, L. M., Wood, W., Rowan, A., Donohue, C., Spain, S. L., Jaeger, E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4074 · Cited by 55
Family history of colorectal cancer in a Sweden county
Olsson, L., & Lindblom, A. (2003) · Familial Cancer · doi:10.1023/a:1025734200635 · Cited by 46
Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
Matsuzaki, K. (2006) · PubMed · doi:10.14670/hh-21.645 · Cited by 45
TGFBR1☆6A May Contribute to Hereditary Colorectal Cancer
Bian, Y., Caldés, T., Wijnen, J., Franken, P., Vasen, H. F. A., Kaklamani, V., Nafa, K., Peterlongo, P., Ellis, N. A., Baron, J. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.281 · Cited by 45
Self-citationKu, J., Park, S. H., Yoon, K., Shin, Y., Kim, K., Choi, J.-S., Kang, H.-C., Kim, I.-J., Han, I., & Park, J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.05.008 · Cited by 43
Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations
Grady, W. M., Willis, J. E., Trobridge, P. A., Romero–Gallo, J., Muñoz, N. M., Olechnowicz, J., Ferguson, K., Gautam, S., & Markowitz, S. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.21399 · Cited by 37
Takaku, K., Wrana, J. L., Robertson, E. J., & Taketo, M. M. (2002) · PubMed · Cited by 28
Is TGFBR1*6A Really Associated With Increased Risk of Cancer?
Zhang, H., Zhao, J., Zheng, S., & Chen, X. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9108 · Cited by 23
Cited by
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Hereditary and Familial Colon Cancer
Jasperson, K. W., Tuohy, T. M., Neklason, D. W., & Burt, R. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.054 · Cited by 1,312
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Signaling pathways involved in colorectal cancer progression
Koveitypour, Z., Panahi, F., Vakilian, M., Peymani, M., Seyed Forootan, F., Nasr Esfahani, M. H., & Ghaedi, K. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0361-4 · Cited by 393
Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer
Valle, L., Serena-Acedo, T., Liyanarachchi, S., Hampel, H., Comeras, I., Li, Z., Zeng, Q., Zhang, H.-T., Pennison, M. J., Sadim, M., et al. (2008) · Science · doi:10.1126/science.1159397 · Cited by 141
Self-citation
Metadata
- Authors
- Xu, Y., & Pasche, B.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R14-R20
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2122934448
- Cited by
- 264
- References
- 60
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.